Poster Session II. - U: Cardiovascular Medicine and Research
Dr. Szabo Liliana, PhD
SE Heart and Vascular Centre
+36304843367
sz.liliana.e@gmail.com
Delineating healthy and pathological cardiovascular aging in the UK Biobank
Liliana Szabo1, Jackie Cooper2, Dorina-Gabriela Condurache2, Dorottya Balla1, Hajnalka Vago1, Bela Merkely1, Steffen E. Petersen2, Zahra Raisi-Estabragh2
1: Semmelweis Univeristy Heart and Vascular Centre
2: William Harvey Research Institute, Queen Mary University of London
Poszter
Poster Session II. - U: Cardiovascular Medicine and Research
English
Cardiovascular Medicine and Research
Background: Cardiovascular aging is a key contributor to ill health and mortality, with distinct differences between healthy and pathological aging. Vascular risk factors (VRFs) and cardiovascular diseases (CVDs) accelerate these aging processes, impacting the structure and function of the heart. However, the specific determinants of these variations remain poorly understood.
Objective: This study aims to delineate the effects of aging on myocardial and vascular structures using comprehensive imaging data from the UK Biobank, and to assess how VRFs and CVDs modify these age-related cardiovascular phenotypes.
Methods: We analyzed cardiovascular magnetic resonance (CMR) data from UK Biobank participants, stratified by sex and presence of VRFs (hypertension, obesity, diabetes, high cholesterol, smoking) and CVDs (ischaemic heart disease, heart failure, arrhythmias, valvular heart disease, non-ischaemic cardiomyopathy, stroke, vascular dementia, or peripheral vascular disease). Linear regression models were used to examine the relationships between age, VRFs, CVDs, and cardiovascular metrics.
Results: The study included 61,266 participants (52% women), aged 44–85 years. Common vascular risk factors (VRFs) were smoking (38%), high cholesterol (36%), and hypertension (33%), with 14% having cardiovascular disease (CVD). Among 24,805 healthy participants, aging was associated with lower LV and RV volumes, reduced LVMi (men: β=-0.020; women: β=-0.004), increased EDWT (more in women), and greater concentricity. Higher age was associated with slightly higher LVEF and LVGCS, and reduced LVGLS (M: -0.007 [-0.010 to -0.004]; F: -0.020 [-0.022 to -0.017]). Participants with VRFs (n=28,047) exhibited similar aging trends but with higher concentricity and more pronounced atrial enlargement. In those with CVD (n=8,414), systolic function declined with age, particularly in men (GLS: -0.016 [-0.021 to -0.011]). Hypertension and obesity promoted concentric remodeling, while diabetes drove reduced volumes and mass. Physical activity had protective effects (concentricity β: -0.03 [-0.04 to -0.03]).
Conclusion: This large, sex-stratified study provides comprehensive insights into the cardiovascular aging process, highlighting the importance of early intervention and lifestyle modifications to mitigate age-related structural deterioration of the heart.
Funding: EKÖP-2024-272
Semmelweis University
Hajnalka Vago
I do not give consent to the publication of my abstract on the website of the congress.
after finishing doctoral studies with absolutorium (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
4153
19:12
19:18